MYL has pretty good protection from TEVA’s hostile offer thanks to a poison pill it implemented under Dutch corporate law, which transfers responsibility for approving a merger to a foundation.
(MYL became a Dutch-domiciled company when it acquired ABT’s European branded-generics business; #msg-110385639.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”